ICARES Medicus, Inc. (TPEX:6612)

Market Cap	3.98B
Revenue (ttm)	1.09B
Net Income (ttm)	63.38M
Shares Out	47.38M
EPS (ttm)	1.34
PE Ratio	62.58
Forward PE	n/a
Dividend	0.27 (0.33%)
Ex-Dividend Date	Aug 22, 2025

Volume	3,583
Average Volume	16,474
Open	84.70
Previous Close	83.90
Day's Range	83.90 - 84.70
52-Week Range	80.46 - 123.64
Beta	0.38
RSI	38.97
Earnings Date	Nov 11, 2025

About ICARES Medicus

ICARES Medicus, Inc., together with its subsidiaries, engages in the design, research, development, manufacture, and sale of intraocular lenses and nanomedical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company offers ophthalmic medical devices, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, and astigmatism; and surgical implant systems, as well as related technical services. It also provides nanomedical lubricious coatings and various surface treatments...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Employees: 64
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6612

Financial Performance

In 2024, ICARES Medicus's revenue was 859.79 million, an increase of 42.01% compared to the previous year's 605.45 million. Earnings were 103.12 million, an increase of 5.52%.